RxDoctor Payments Data

Evan Wuthrick, MD

Radiation Oncology · Columbus, OHNPI 1588870323

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,976 of the $21,370 with a category attached, or 74.8%. 6 manufacturers reported payments, led by Viewray Technologies Inc at 49.8% of the total. Reporting peaked in 2022 at $10,907 and has fallen 88.5% since, to $1,259 in 2025. Among radiation oncology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,370in general payments, 2019–2025

Across 23 payments — averaging $929.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viewray Technologies Inc$11K
  • Sanofi$5K
  • Varian Medical Systems, Inc.$3K
  • Regeneron$2K
  • Elekta, Inc.$1K
  • Merck$19

What the payments were for

  • Consulting fees$15,97675%
  • Travel & lodging$4,39421%
  • Food & beverage$1,0005%

General payments by program year

19
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viewray Technologies Inc3$10,648
Sanofi2$4,670
Varian Medical Systems, Inc.2$3,340
Regeneron8$1,517
Elekta, Inc.7$1,177
Merck1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,370 in reported general payments places this provider in the 95th percentile of 255 radiation oncology providers in Ohio.

See all radiation oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$263,024
Medicare patients
325
Services billed
3,124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SsdSilver Sulfadiazine16$160

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →